AccuMetab™ Human SULT Control Cytosol Fraction

CAT#: ITS-0426-YL103
Product Type: Control Fraction
Brand: AccuMetab
Development Stage: ADME
ADME Research Domain: Metabolism
Short Description
Zero-background cytosol control for accurate ADME assay baseline validation.
Brand
AccuMetab
Development Stage
ADME
ADME Research Domain
Metabolism
Background
Derived from native host cell cytosol, this control product is devoid of recombinant human sulfotransferase activity. ADME researchers depend on this blank fraction to eliminate background noise, correct for endogenous host metabolism, and ensure the high-fidelity readout of Phase II sulfation assays.
Key Features
Native host cytosol lacking recombinant sulfotransferases; Absolute zero-background baseline for Phase II SULT validation; Isolates true Phase II sulfation from endogenous host metabolism; Strictly quantifies non-specific chemical degradation
Applications
Background Subtraction, Assay Control
Research Areas
ADME; Assay Control
Expression System
E. coli host cytosolic fraction preparations.
Physical Form
Liquid
Size
0.5 nmol; 1 nmol; 4 nmol; 10 mg
Storage
-80°C
Storage Comment
When stored at -80°C, our product remains stable and retains full functional activity for up to 10 years.
Note
For bulk pricing or custom reagent inquiries, please contact us by email or phone. Products are shipped on ice via FedEx.
Restrictions
For Research Use Only (RUO). Not intended for diagnostic or therapeutic use.
Shipping
Our enzyme products are shipped at -80°C.
For Research Use Only | Not For Clinical Use
Online Inquiry